Ⅱ~Ⅳ期乳腺癌患者中Panagen激活继发性免疫反应和白细胞活性的Ⅱ期多中心双盲安慰剂对照临床研究

    Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer

    /

    返回文章
    返回